Investors in Genetics

Displaying 1-10 out of 1040

Versant Ventures

Versant Ventures is a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great companies. The firm invests across the healthcare sector and at all stages of company development, with an emphasis on the discovery and development of novel therapeutics. With $2.3 billion under management and offices in Canada, the U.S. and Europe, Versant has built a team with deep investment, operating, and scientific expertise that enables a hands-on approach to company building. Since the firm’s founding in 1999, more than 65 Versant companies have achieved successful acquisitions or IPOs.
+24
Made 27 investments in Genetics

SOSV

SOSV is venture capital firm and an accelerator specializing in technology startups. The firm also specializes in seed, early venture, growth capital, venture and growth-stage funding to disruptive startups. The firm typically invests in information technology with a focus on hardware, software, leap motion, sales and biotechnology, telecommunications, energy efficiency technology, energy, green energy, medical devices, transportation, robotics, internet, and social media; it also invests in the food sector. It seeks to invest globally with a focus on United States, Europe, and Asia including China. The firm typically invests between $0.01 million and $0.05 million and offers a two-four month program in exchange for equity. The firm prefers to invest as the lead investor. SOSV was founded in 1995 and is based in Princeton, New Jearsey with additional offices in United States of America, Europe, and Asia.
+12
Made 69 investments in Genetics

Fidelity

Fidelity is a privately owned investment manager. It also provides IRAs, 401(k) rollovers, annuities, discount brokerage services, retirement services, estate planning, wealth management, securities execution and clearance, and life insurance services to its clients. Fidelity provides its services to individual investors, businesses, financial advisors, and institutions. It manages equity, fixed income, and balanced mutual funds. Fidelity invests in the public equity and fixed income markets across the globe. It conducts in-house research to make its investments. Fidelity operates as a subsidiary of FMR LLC. It began operation in 1946, with its headquarters in Boston in Massachusetts.
BJ
GJ
Made 43 investments in Genetics

Alexandria

Alexandria Venture Investments is a strategic venture capital arm of Alexandria Real Estate Equities. Alexandria Venture Investments provides long-term strategic investment capital to innovative life science and technology entities developing breakthrough technologies and therapies. Leveraging their experience and in-depth understanding of the life science and technology industries, their long-term relationships with leading investors, and their world-class scientific advisory network, they are uniquely positioned to fund seed-, early-, and growth-stage companies.
TM
JC
LD
+6
Made 47 investments in Genetics

Kurma Partners

Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovations in Europe, particularly through links with many institutes. research and prestigious hospitals.
+10
Made 21 investments in Genetics

Sequoia Capital

Sequoia Capital Global Equities extends Sequoia Capital’s technology investing efforts into the public markets. SCGE currently manages over $7 billion and invests in companies across the global technology, media, and telecommunications (TMT) sectors, primarily focusing on software, internet, financial technology, and technology-enabled consumer businesses. The firm’s portfolio consists of concentrated, long-term investments in leading companies across the world. While the majority of the portfolio is comprised of public companies, SCGE also partners with entrepreneurs through late-stage private crossover investments, often investing alongside Sequoia Growth funds. The firm’s private portfolio includes emerging leaders in the United States, China, India, Brazil, Korea, and Israel. As these private companies become public, SCGE grows the partnership with additional investments at the IPO and beyond.
MP
+71
Made 52 investments in Genetics

Wellington Management

Wellington Management Company is a Boston based institutional investment advisor firm. The firm invests in global equity, fixed income, currency and commodity markets, multi-strategy, specialty and alternative investments. The firm offers separate accounts and a wide range of commingled vehicles that include both US and non-US domiciled portfolios. The company was founded in 1928.
PE
+8
Made 14 investments in Genetics

IMM Investment

IMM Investment Corp. is a private equity and venture capital firm specializing in mezzanine investments. It focuses on mergers and acquisitions, venture capital investing, corporate restructuring, private equity investing, industry consolidation, management buyouts, spin-offs, recapitalizations, and cross-border investments. Within mergers and acquisitions, the firm invests in strategic mergers, growth through acquisitions, going public via a reverse merger, and strategic divestures. For recapitalizations, it targets family owned enterprise considering whole or partial exit and balance sheet restructuring. The firm also co-invests in buyout transactions. For its growth stage investments, it allocates 20 percent to startups, 40 percent to expansion, and 40 percent to mezzanine. The firm targets companies operating in information technology infrastructure, wireless communications entertainment and contents, franchising, cement, software, electricity, food and beverage, machinery, game software, chemical, paper manufacture, and automobile parts industries. For industries concentration, it sets 40 percent to information technology infrastructure focusing on security, application service provider, and e-commerce solutions; 30 percent to contents, focusing on education, game, and animation; and 30 percent to digital hardware focusing on network and communications equipment, semiconductor, parts and others. The firm also invests in infrastructure, environment, manufacturing, enzyme, biotechnology, and healthcare sectors. It also makes secondary investments. The firm primarily invests in South Korean medium-sized companies located in Seoul, Gyeonggi, Daegu, Gyeongsangbuk-do, and Chungcheongbuk-do. It prefers to take an active role in management. IMM Investment Corp. was founded in July 1999 and is based in Seoul, South Korea.
DJ
IC
IJ
+4
Made 7 investments in Genetics

Casdin Capital

Casdin Capital, LLC is an investment firm focused on the life sciences and healthcare industry.
JM
+4
Made 36 investments in Genetics

SoftBank

The SoftBank Group is a global technology player that aspires to drive the Information Revolution. The SoftBank Group is comprised of the holding company SoftBank Group Corp. and its global portfolio of companies, which includes advanced telecommunications, internet services, AI, smart robotics, IoT and clean energy technology providers. In September 2016, Arm Holdings plc, the world's leading semiconductor IP company, joined the SoftBank Group. In May 2017, the SoftBank Vision Fund, which invests globally in the businesses and technologies that will enable the next stage of the Information Revolution, had its first major close with over USD 93 billion in committed capital.
+2
Made 17 investments in Genetics
Register to see full results
Unregistered visitors can only see the top 10 results. Register now to get unlimited access to all profiles.
Get full access